These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36980165)

  • 1. Anticancer Activity of Bitter Melon-Derived Vesicles Extract against Breast Cancer.
    Feng T; Wan Y; Dai B; Liu Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
    Raina K; Kumar D; Agarwal R
    Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
    Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
    Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Bitter Melon in Breast and Gynecological Cancer Prevention and Therapy.
    Psilopatis I; Vrettou K; Giaginis C; Theocharis S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Antitumor Activities of the Bitter Melon (Momordica charantia).
    Fang EF; Froetscher L; Scheibye-Knudsen M; Bohr VA; Wong JH; Ng TB
    Curr Protein Pept Sci; 2019; 20(3):296-301. PubMed ID: 29932035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bitter melon derived extracellular vesicles enhance the therapeutic effects and reduce the drug resistance of 5-fluorouracil on oral squamous cell carcinoma.
    Yang M; Luo Q; Chen X; Chen F
    J Nanobiotechnology; 2021 Aug; 19(1):259. PubMed ID: 34454534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bitter melon: a panacea for inflammation and cancer.
    Dandawate PR; Subramaniam D; Padhye SB; Anant S
    Chin J Nat Med; 2016 Feb; 14(2):81-100. PubMed ID: 26968675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
    Ray RB; Raychoudhuri A; Steele R; Nerurkar P
    Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
    Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
    Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bitter melon (Momordica charantia): a review of efficacy and safety.
    Basch E; Gabardi S; Ulbricht C
    Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of
    Kilcar AY; Yildiz O; Dogan T; Sulu E; Takan G; Muftuler FZB
    Anticancer Agents Med Chem; 2020; 20(12):1497-1503. PubMed ID: 32329694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Momordica charantia L. induces non-apoptotic cell death in human MDA-MB-436 breast and A549 lung cancer cells by disrupting energy metabolism and exacerbating reactive oxygen species' generation.
    Ehigie AF; Wei P; Wei T; Yan X; Olorunsogo OO; Ojeniyi FD; Ehigie LO
    J Ethnopharmacol; 2021 Sep; 277():114036. PubMed ID: 33753145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
    Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
    J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bitter melon extract inhibits proliferation of Trypanosoma brucei bloodstream forms in vitro.
    Phillips EA; Sexton DW; Steverding D
    Exp Parasitol; 2013 Mar; 133(3):353-6. PubMed ID: 23266484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bitter Melon (
    Sur S; Ray RB
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bitter Melon Extract Yields Multiple Effects on Intestinal Epithelial Cells and Likely Contributes to Anti-diabetic Functions.
    Chang CI; Cheng SY; Nurlatifah AO; Sung WW; Tu JH; Lee LL; Cheng HL
    Int J Med Sci; 2021; 18(8):1848-1856. PubMed ID: 33746602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the key metabolic pathways, glycolysis and lipogenesis, of oral cancer by bitter melon extract.
    Sur S; Nakanishi H; Flaveny C; Ippolito JE; McHowat J; Ford DA; Ray RB
    Cell Commun Signal; 2019 Oct; 17(1):131. PubMed ID: 31638999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal treatment enhances the α-glucosidase inhibitory activity of bitter melon (Momordica charantia) by increasing the free form of phenolic compounds and the contents of Maillard reaction products.
    Hsieh HJ; Lin JA; Chen KT; Cheng KC; Hsieh CW
    J Food Sci; 2021 Jul; 86(7):3109-3121. PubMed ID: 34146408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Biological Activities of Wild Bitter Melon (
    Pham TMH; Ngo DH; Ngo DN; Vo TS
    Biomolecules; 2019 May; 9(6):. PubMed ID: 31151277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.